These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
432 related items for PubMed ID: 15984693
21. A radiobiological investigation on dose and dose rate for permanent implant brachytherapy of breast using 125I or 103Pd sources. Baltas D, Lymperopoulou G, Löffler E, Mavroidis P. Med Phys; 2010 Jun; 37(6):2572-86. PubMed ID: 20632569 [Abstract] [Full Text] [Related]
23. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants. Chibani O, Williamson JF, Todor D. Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786 [Abstract] [Full Text] [Related]
26. On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources. Chan GH, Nath R, Williamson JF, American Association of Physicists in Medicine. Med Phys; 2004 May; 31(5):1040-5. PubMed ID: 15191290 [Abstract] [Full Text] [Related]
27. Perturbation of TG-43 parameters of the brachytherapy sources under insufficient scattering materials. Zehtabian M, Sina S, Faghihi R, Meigooni A. J Appl Clin Med Phys; 2013 May 06; 14(3):4228. PubMed ID: 23652255 [Abstract] [Full Text] [Related]
30. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source. Chan GH, Prestwich WV. Med Phys; 2002 Sep 06; 29(9):1984-90. PubMed ID: 12349919 [Abstract] [Full Text] [Related]
33. Dosimetric study of a new polymer encapsulated palladium-103 seed. Bernard S, Vynckier S. Phys Med Biol; 2005 Apr 07; 50(7):1493-504. PubMed ID: 15798339 [Abstract] [Full Text] [Related]
34. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources. Nath R, Meigooni AS, Muench P, Melillo A. Med Phys; 1993 Apr 07; 20(5):1465-73. PubMed ID: 8289730 [Abstract] [Full Text] [Related]
35. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO. Rivard MJ, Ballester F, Butler WM, DeWerd LA, Ibbott GS, Meigooni AS, Melhus CS, Mitch MG, Nath R, Papagiannis P. Med Phys; 2017 Sep 07; 44(9):e297-e338. PubMed ID: 28644913 [Abstract] [Full Text] [Related]
36. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed. Pantelis E, Lymperopoulou G, Papagiannis P, Sakelliou L, Stiliaris E, Sandilos P, Seimenis I, Kozicki M, Rosiak JM. Phys Med Biol; 2005 Sep 21; 50(18):4371-84. PubMed ID: 16148399 [Abstract] [Full Text] [Related]
37. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources. Awan SB, Meigooni AS, Mokhberiosgouei R, Hussain M. Med Phys; 2006 Nov 21; 33(11):4271-9. PubMed ID: 17153405 [Abstract] [Full Text] [Related]
38. A discretized approach to determining TG-43 brachytherapy dosimetry parameters: case study using Monte Carlo calculations for the MED3633 103Pd source. Rivard MJ. Appl Radiat Isot; 2001 Dec 21; 55(6):775-82. PubMed ID: 11761099 [Abstract] [Full Text] [Related]
40. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources. Bannon EA, Yang Y, Rivard MJ. Med Phys; 2011 Jun 21; 38(6):2957-63. PubMed ID: 21815369 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]